Earnings Feed
Start Free
$CYTK·4

CYTOKINETICS INC · Mar 2, 7:07 PM ET

CYTOKINETICS INC 4

4 · CYTOKINETICS INC · Filed Mar 2, 2017

Insider Transaction Report

Form 4
Period: 2017-02-28
CYTOKINETICS INCCYTK
WOLFF ANDREW A
SVP Clinical R&D, CMO
Transactions
  • Award

    Common Stock

    2017-02-28$0.00/sh+12,500$13→ 37,239 total
  • Award

    Common Stock

    2017-02-28$0.00/sh+15,000$15→ 47,255 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2017-02-28+8,580→ 8,580 total
    Exercise: $10.60Exp: 2027-02-28→ Common Stock (8,580 underlying)
  • Award

    Incentive Stock Option (right to buy)

    2017-02-28+6,420→ 6,420 total
    Exercise: $10.60Exp: 2027-02-28→ Common Stock (6,420 underlying)
  • Tax Payment

    Common Stock

    2017-02-28$10.60/sh−4,984$52,830→ 32,255 total
Footnotes (2)
  • [F1]The restricted stock units vest in three annual installments. Vested shares will be delivered to the reporting person as follows: 40% on 02/28/2018, 40% on 02/28/2019 and 20% on 02/28/2020.
  • [F2]When the ISO and NQ dated 02/28/2017 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/28/2021.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT